Limbic

About Limbic

Limbic is a company focused on providing clinical AI solutions for mental healthcare providers. Their mission is to help behavioral health organizations scale access, speed up care, and improve outcomes without increasing staff or sacrificing quality, addressing the unsustainable demand in mental health services with innovative AI technology.

Products & Services

Limbic Access:A clinical AI assistant for patient intakes and assessments, embeddable in websites for mobile, tablet, and desktop access.

Limbic Care:A clinical AI companion providing on-demand support for mental healthcare.

Specialties

Clinical AI Behavioral Health Generative AI for Healthcare Computational Psychiatry Cognitive Behavioral Therapy (CBT) via AI Patient Intake and Triage

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 14000000 MR: - FA: $14 million FAN: 14000000	D: 2024-03-05 FD: 2024-03-05	3 investors

Series A Latest

2024-03-05

$14.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Sarah

R

Ross Harper

CEO

S

Sebastiaan de Vries

CTO

B

Bruce Armstrong

NED

A

Adina Tecklu

Associate NED

M

Max Rollwage

VP of AI & Research

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Limbic Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised